Options Data for US Stocks: End-of-Day and Historical Learn more

Charles River Laboratories icon

Charles River Laboratories (CRL NYSE) stock market data APIs

$338.8307 27.5(8.1%)
as of November 2, 2026
Try our APIs with free plan!

Charles River Laboratories Financial Data Overview

Price chart is built with Anychart

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization; and Medigen Vaccine Biologics Corp for developing next-generation multivalent enterovirus vaccine, enhance global regulatory readiness, and support IND-enabling non-clinical studies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Prev. Close 338.8307
Open 366.3267
High 371.4329
Low 338.4104
52 wk Range 146.195-379.63
Market Cap 17 312 M
Shares Outstanding 48 168 K
Revenue 3 999 M
Beta 1.404

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Charles River Laboratories (top by weight)

Ticker
100-day Price Change
Weight
FMTM.US MarketDesk Focused U.S. Momentum ETF
-0.25 (-0.65%)
4.08
EPAI.US Harbor AI Inflection Strategy ETF
-2.35 (-8.78%)
3.81
EPSB.US Harbor SMID Cap Core ETF
-0.47 (-1.73%)
3.56
SAMM.US The Advisors’ Inner Circle Fund III
0.9 (2.89%)
3.24
EPSV.US Harbor SMID Cap Value ETF
-1.17 (-3.79%)
2.65
QMOM.US Alpha Architect U.S. Quantitative Momentum ETF
-5.27 (-7.04%)
2.54
PTH.US Invesco DWA Healthcare Momentum ETF
-0.78 (-1.33%)
2.49
EPMV.US Harbor Mid Cap Value ETF
-0.42 (-1.56%)
2.35
ARGFX.US ARIEL FUND INVESTOR CLASS
3.35 (4.09%)
2.13
CBSM.XETRA Franklin ClearBridge US Smaller Companies UCITS ETF (Acc)
-0.23 (-2.37%)
1.97

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Charles River Laboratories data using free add-ons & libraries


Get Charles River Laboratories Fundamental Data

Charles River Laboratories logo

Charles River Laboratories Fundamental data includes:

  • Net Revenue: 3 999 M
  • EBITDA: 849 M
  • Earnings Per Share: -4
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Charles River Laboratories Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-11-04
  • EPS/Forecast: 2.98
GET THE PACKAGE

Get Charles River Laboratories End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Charles River Laboratories News

Get Charles River Laboratories fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE

Send the request

Leave your email and our team will contact you ASAP.